Deciphera Pharmaceuticals LLC Probability of Future Stock Price Finishing Over 15.95
| DCPHDelisted Stock | USD 13.32 0.36 2.63% |
Deciphera |
Deciphera Pharmaceuticals Target Price Odds to finish over 15.95
The tendency of Deciphera Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 15.95 or more in 90 days |
| 13.32 | 90 days | 15.95 | near 1 |
Based on a normal probability distribution, the odds of Deciphera Pharmaceuticals to move over $ 15.95 or more in 90 days from now is near 1 (This Deciphera Pharmaceuticals LLC probability density function shows the probability of Deciphera Stock to fall within a particular range of prices over 90 days) . Probability of Deciphera Pharmaceuticals price to stay between its current price of $ 13.32 and $ 15.95 at the end of the 90-day period is roughly 96.0 .
Given the investment horizon of 90 days Deciphera Pharmaceuticals has a beta of 0.2 suggesting as returns on the market go up, Deciphera Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Deciphera Pharmaceuticals LLC will be expected to be much smaller as well. Additionally Deciphera Pharmaceuticals LLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Deciphera Pharmaceuticals Price Density |
| Price |
Predictive Modules for Deciphera Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Deciphera Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Deciphera Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Deciphera Pharmaceuticals is not an exception. The market had few large corrections towards the Deciphera Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Deciphera Pharmaceuticals LLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Deciphera Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.23 | |
β | Beta against Dow Jones | 0.20 | |
σ | Overall volatility | 0.42 | |
Ir | Information ratio | -0.15 |
Deciphera Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Deciphera Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Deciphera Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Deciphera Pharmaceuticals is not yet fully synchronised with the market data | |
| Deciphera Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 163.36 M. Net Loss for the year was (194.94 M) with loss before overhead, payroll, taxes, and interest of (62.55 M). | |
| Deciphera Pharmaceuticals LLC currently holds about 383.85 M in cash with (146.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74. | |
| Roughly 72.0% of the company shares are held by institutions such as insurance companies |
Deciphera Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Deciphera Stock often depends not only on the future outlook of the current and potential Deciphera Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Deciphera Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 85.1 M | |
| Cash And Short Term Investments | 306.2 M |
Deciphera Pharmaceuticals Technical Analysis
Deciphera Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Deciphera Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Deciphera Pharmaceuticals LLC. In general, you should focus on analyzing Deciphera Stock price patterns and their correlations with different microeconomic environments and drivers.
Deciphera Pharmaceuticals Predictive Forecast Models
Deciphera Pharmaceuticals' time-series forecasting models is one of many Deciphera Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Deciphera Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Deciphera Pharmaceuticals
Checking the ongoing alerts about Deciphera Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Deciphera Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Deciphera Pharmaceuticals is not yet fully synchronised with the market data | |
| Deciphera Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 163.36 M. Net Loss for the year was (194.94 M) with loss before overhead, payroll, taxes, and interest of (62.55 M). | |
| Deciphera Pharmaceuticals LLC currently holds about 383.85 M in cash with (146.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74. | |
| Roughly 72.0% of the company shares are held by institutions such as insurance companies |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Deciphera Stock
If you are still planning to invest in Deciphera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deciphera Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |